AAAAAA
Results:
1-16
|
Results: 16
Authors:
Offen, D
Panet, H
Galili-Mosberg, R
Melamed, E
Citation: D. Offen et al., Catechol-O-methyltransferase decreases levodopa toxicity in vitro, CLIN NEUROP, 24(1), 2001, pp. 27-30
Authors:
Gilgun-Sherki, Y
Melamed, E
Offen, D
Citation: Y. Gilgun-sherki et al., Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier, NEUROPHARM, 40(8), 2001, pp. 959-975
Authors:
Vila, M
Jackson-Lewis, V
Vukosavic, S
Djaldetti, R
Liberatore, G
Offen, D
Korsmeyer, SJ
Przedborski, S
Citation: M. Vila et al., Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease, P NAS US, 98(5), 2001, pp. 2837-2842
Authors:
Panet, H
Barzilai, A
Daily, D
Melamed, E
Offen, D
Citation: H. Panet et al., Activation of nuclear transcription factor kappa B (NF-kappa B) is essential for dopamine-induced apoptosis in PC12 cells, J NEUROCHEM, 77(2), 2001, pp. 391-398
Authors:
Daily, D
Vlamis-Gardikas, A
Offen, D
Mittelman, L
Melamed, E
Holmgren, A
Barzilai, A
Citation: D. Daily et al., Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the Ras-phosphoinositide 3-kinase and jun N-terminal kinase pathways, J BIOL CHEM, 276(24), 2001, pp. 21618-21626
Authors:
Daily, D
Vlamis-Gardikas, A
Offen, D
Mittelman, L
Melamed, E
Holmgren, A
Barzilai, A
Citation: D. Daily et al., Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by activating NF-kappa B via Ref-1, J BIOL CHEM, 276(2), 2001, pp. 1335-1344
Authors:
Ziv, I
Shirvan, A
Offen, D
Barzilai, A
Melamed, E
Citation: I. Ziv et al., Molecular biology of dopamine-induced apoptosis - Possible implications for Parkinson's disease, METH MOL M, 62, 2001, pp. 73-87
Authors:
Offen, D
Kaye, JF
Bernard, O
Merims, D
Coire, CI
Panet, H
Melamed, E
Ben-Nun, A
Citation: D. Offen et al., Mice overexpressing bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE), J MOL NEURO, 15(3), 2000, pp. 167-176
Authors:
Melamed, E
Offen, D
Shirvan, A
Ziv, I
Citation: E. Melamed et al., Levodopa - an exotoxin or a therapeutic drug?, J NEUROL, 247, 2000, pp. 135-139
Authors:
Offen, D
Elkon, H
Melamed, E
Citation: D. Offen et al., Apoptosis as a general cell death pathway in neurodegenerative diseases, J NEUR TR-S, (58), 2000, pp. 153-166
Authors:
Galili-Mosberg, R
Gil-Ad, I
Weizman, A
Melamed, E
Offen, D
Citation: R. Galili-mosberg et al., Haloperidol - induced neurotoxicity - possible implications for tardive dyskinesia, J NEURAL TR, 107(4), 2000, pp. 479-490
Authors:
Hochman, A
Liang, HY
Offen, D
Melamed, E
Sternin, H
Citation: A. Hochman et al., Developmental changes it antioxidant enzymes and oxidative damage in kidneys, liver and brain of bcl-2 knockout mice, CELL MOL B, 46(1), 2000, pp. 41-52
Authors:
Offen, D
Sherki, Y
Melamed, E
Fridkin, M
Brenneman, DE
Gozes, I
Citation: D. Offen et al., Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease, BRAIN RES, 854(1-2), 2000, pp. 257-262
Authors:
Offen, D
Gorodin, S
Melamed, E
Hanania, J
Malik, Z
Citation: D. Offen et al., Dopamine-melanin is actively phagocytized by PC12 cells and cerebellar granular cells: possible implications for the etiology of Parkinson's disease, NEUROSCI L, 260(2), 1999, pp. 101-104
Authors:
Daily, D
Barzilai, A
Offen, D
Kamsler, A
Melamed, E
Ziv, I
Citation: D. Daily et al., The involvement of p53 in dopamine-induced apoptosis of cerebellar granuleneurons and leukemic cells overexpressing p53, CELL MOL N, 19(2), 1999, pp. 261-276
Authors:
Offen, D
Mosberg, R
Stern-Goldberg, H
Melamed, E
Halevi, S
Orion, D
Atlas, D
Citation: D. Offen et al., Antibodies from ALS patients inhibit dopamine release mediated by L-type calcium channels - Reply, NEUROLOGY, 52(7), 1999, pp. 1520-1521
Risultati:
1-16
|